Valuation: GI Innovation, Inc.

Market Cap 454B 342M 307M 283M 257M 480M 32.47B 486M 3.4B 1.35B 17.02B 1.28B 1.26B 53.97B P/E 2024
-6.04x
P/E 2025 -29.2x
Enterprise Value 419B 316M 283M 262M 237M 443M 29.99B 449M 3.14B 1.25B 15.72B 1.19B 1.16B 49.85B EV / Sales 2024
15,970x
EV / Sales 2025 187x
Free-Float
93.32%
Yield 2024 *
-
Yield 2025 -
1 day-8.22%
1 week-14.48%
Current month-11.57%
1 month-20.74%
3 months-6.76%
6 months-56.12%
Current year-60.15%
1 week 7,010
Extreme 7010
8,670
1 month 7,010
Extreme 7010
9,740
Current year 6,470
Extreme 6470
18,830
1 year 6,470
Extreme 6470
20,950
3 years 6,470
Extreme 6470
24,900
5 years 6,470
Extreme 6470
24,900
10 years 6,470
Extreme 6470
24,900
Manager TitleAgeSince
Chief Executive Officer 58 01/07/2025
Chief Executive Officer 54 15/06/2021
Director of Finance/CFO - 31/08/2024
Director TitleAgeSince
Director/Board Member 54 15/06/2021
Director/Board Member 58 30/06/2017
Director/Board Member 64 28/02/2022
Date Insider Type Main position Quantity % Market Cap. Importance
20/01/26 Expiration 14 0.0000% -
20/01/26 Exercice

Chief Technology Officer

445 0.0007%
20/01/26 Exercice 14 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
-8.22%-14.48%-53.01%-7.89% 372M
-3.10%-3.43%+36.29%+67.69% 65.28B
+0.33%+7.26%+11.51%+77.95% 54.57B
+0.16%+3.69%+8.39%+101.27% 53.59B
-0.75%+2.13%+23.14%+47.25% 45.03B
-1.30%-1.11%+17.77%+120.71% 42.17B
+1.26%+2.23%+241.81%+835.31% 39.42B
-0.74%-4.84%+14.53%+44.45% 32.71B
-2.70%-7.34%+23.17%+0.36% 24.01B
+1.11%+17.90%+56.87%+47.78% 26.5B
Average -1.40%+0.50%+38.05%+133.49% 38.36B
Weighted average by Cap. -0.72%+1.70%+45.06%+148.49%

Financials

2024 2025
Net sales 24.28M 18.3K 16.43K 15.17K 13.75K 25.71K 1.74M 26.02K 182K 72.22K 911K 68.7K 67.23K 2.89M 5.84B 4.4M 3.95M 3.65M 3.31M 6.18M 418M 6.26M 43.72M 17.36M 219M 16.52M 16.16M 695M
Net income -58.78B -44.31M -39.77M -36.72M -33.3M -62.23M -4.21B -63M -440M -175M -2.21B -166M -163M -7B -35.13B -26.48M -23.77M -21.95M -19.9M -37.19M -2.52B -37.65M -263M -104M -1.32B -99.4M -97.28M -4.18B
Net Debt -3.44B -2.59M -2.33M -2.15M -1.95M -3.64M -246M -3.69M -25.76M -10.23M -129M -9.73M -9.52M -409M -34.63B -26.1M -23.42M -21.63M -19.61M -36.66M -2.48B -37.11M -259M -103M -1.3B -97.97M -95.87M -4.12B
Projected Income Statement - Annual - GI Innovation, Inc.
Logo GI Innovation, Inc.
GI Innovation Inc is a Korea-based company engaged in the research and development of next-generation immunotherapies based on fusion proteins. The Company is engaged in the business of generating revenue through license fees by technology transfer of new drug candidates in pre-clinical and early clinical stages. The core new drug pipeline includes products such as GI-101 immuno-oncology and GI-301 allergy treatment.
Employees
-
Date Price Change Volume
27/10/26 ₩7,030.00 -8.22% 340,962
26/10/26 ₩7,660.00 -0.78% 178,056
23/10/26 ₩7,720.00 -1.28% 175,454
22/10/26 ₩7,820.00 -2.98% 138,202
21/10/26 ₩8,060.00 -1.71% 195,723
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
CCC
  1. Stock Market
  2. Stocks
  3. A358570 Stock